Immediate Impact
1 from Science/Nature 74 standout
Citing Papers
Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study
2025 Standout
Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
2025 Standout
Works of Issam Tout being referenced
Hepatitis B surface antigen seroclearance: Immune mechanisms, clinical impact, importance for drug development
2020
Characterization of the Inflammasome in Human Kupffer Cells in Response to Synthetic Agonists and Pathogens
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Issam Tout | 287 | 245 | 97 | 15 | 405 | |
| Suzanne Faure‐Dupuy | 278 | 221 | 110 | 13 | 362 | |
| Fengchao Xu | 268 | 228 | 149 | 19 | 371 | |
| Kim Kreefft | 218 | 242 | 236 | 13 | 455 | |
| Louis Jansen | 358 | 307 | 63 | 22 | 421 | |
| Stéphanie Pascarella | 214 | 231 | 51 | 13 | 348 | |
| Shuanghu Liu | 208 | 215 | 91 | 11 | 399 | |
| Chih‐Feng Wu | 324 | 260 | 45 | 9 | 440 | |
| Shintaro Ogawa | 354 | 322 | 31 | 29 | 424 | |
| Le Huu Song | 225 | 182 | 83 | 19 | 425 | |
| Hideko Nuriya | 175 | 149 | 160 | 14 | 414 |
All Works
Login with ORCID to disown or claim papers
Loading papers...